Viewing Study NCT00284258


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-05-24 @ 7:51 AM
Study NCT ID: NCT00284258
Status: COMPLETED
Last Update Posted: 2012-11-02
First Post: 2006-01-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Sponsor: Taiho Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colorectal Cancer View